The Latest Breaking News from ISRG

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 15 years by 12.08% on an annualized basis producing an average annual return of 18.33%. Currently, Intuitive Surgical has a market capitalization of $69.16 billion.

Growing demand for critical surgical procedures and increasing investments in R&D should drive the medical devices industry’s growth. Prominent medical device companies Becton Dickinson (BDX) and Intuitive Surgical (ISRG) are well-positioned to capitalize on the industry tailwinds. But which of these stocks is a better buy now? Read more to…

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 10 years by 2.63% on an annualized basis producing an average annual return of 14.43%. Currently, Intuitive Surgical has a market capitalization of $85.51 billion.

Wells Fargo writes that despite the beat in Q1, Intuitive Surgical Inc (NASDAQ:ISRG) sounded cautious on U.S. capital placements, given rising interest rates and inflationary pressure at hospitals.  "We think this commentary was partly driven by the need to recalibrate Street models for fewer trade-ins as the number of legacy Si systems declines. Overall,…

Intuitive Surgical (NASDAQ:ISRG) reported its Q1 earnings results on Thursday, April 21, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Robotic surgery giant Intuitive Surgical late Thursday beat Wall Street's targets for the first quarter as elective surgeries rebounded.

Intuitive Surgical (NASDAQ:ISRG) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Intuitive Surgical will report an earnings per share (EPS) of $1.08.

Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 5 years by 12.99% on an annualized basis producing an average annual return of 26.41%. Currently, Intuitive Surgical has a market capitalization of $105.91 billion.

Increased focus on elective surgeries and growing demand from the aging population have been helping medical device companies to grow their revenues. Moreover, continuous innovations and the integration of advanced technologies position the industry well for growth. Therefore, prominent players in this space, Intuitive Surgical (ISRG) and Medtronic (MDT), should…

Raymond James has outlined its expectations for next week when Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), and Intuitive Surgical Inc (NASDAQ:ISRG) will report Q1 FY22 earnings. Analysts believe that the Med Tech investors have become somewhat 'paralyzed' given the macro/factor-driven concerns.  On the macro, investor attention seems to be focused less on revenue growth and more…

Within the last quarter, Intuitive Surgical (NASDAQ:ISRG) has observed the following analyst ratings: